Tesla's AI Chip Progress Fuels Stock Surge, But Core Investment Risks Remain Unaddressed

What happened

Tesla's stock price rose nearly 12% over five trading days, pushing its market capitalization to around $1.2 trillion, following reports that its AI5 chip design has been finalized and sent for manufacturing. This development is a positive step for Tesla's autonomy and AI infrastructure, which are central to its long-term valuation narrative. However, the DeepValue master report indicates that Tesla's valuation at over $1.3 trillion already embeds rapid monetization of self-driving technology, despite lacking concrete evidence. Critical unresolved factors include the NHTSA's EA26002 investigation into FSD performance in reduced visibility and the need for sustained growth in subscription-based deferred revenue. Consequently, this chip news does not alter the fundamental risk profile that supports a 'WAIT' rating with an attractive entry point of $280.

Implication

The stock increase reflects market enthusiasm for Tesla's AI advancements but overlooks significant vulnerabilities outlined in filings. The NHTSA's EA26002 probe could lead to functional restrictions on FSD, impairing Robotaxi scaling and subscription economics. Tesla must also show auditable growth in automotive deferred revenue from FSD subscriptions to justify its premium valuation. With 2026 capex expected to exceed $20 billion, cash flow sustainability is at risk if autonomy monetization lags. Therefore, waiting for clarity on regulatory outcomes and revenue trends remains prudent before considering new positions.

Thesis delta

The AI5 chip tape-out does not change the core investment thesis, which hinges on regulatory clearance and measurable software revenue growth. Investors should continue to prioritize datapoints from NHTSA's EA26002 resolution and quarterly deferred revenue updates. No shift in the 'WAIT' recommendation is justified, as the news lacks material impact on the identified risks.